[1]
“Low dose intradetrusor injections of onabotulinumtoxinA in women with overactive bladder symptoms or the painful bladder syndrome: unfavorable balance between clinical efficacy and the need for catheterization”, UIJ, vol. 26, p. e10, Oct. 2012, doi: 10.4081/uij.2012.e10.